Systemic lupus erythematosus - Diagnosis and treatment

被引：27

作者：

Pisetsky, DS ^{[1
]}

Gilkeson, G ^{[1
]}

StClair, EW ^{[1
]}

机构：

[1] DUKE UNIV, MED CTR, DIV RHEUMATOL ALLERGY & CLIN IMMUNOL, DURHAM, NC USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1997年 / 81卷 / 01期

关键词：

D O I：

10.1016/S0025-7125(05)70507-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systemic lupus erythematosus is a multisystem inflammatory disease characterized by antinuclear antibody production. The diagnosis of this disease is established on the basis of a constellation of clinical and serologic features. Therapy is directed to specific disease manifestations and involves an array of antiinflammatory and immunosuppressive agents that are administered judiciously to limit toxicity.

引用

页码：113 / +

页数：1

共 47 条

[1] THE NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS - AN OVERVIEW [J].

ADELMAN, DC ;

SALTIEL, E ;

KLINENBERG, JR .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1986, 15 (03) :185-199

[2] LONG-TERM FOLLOW-UP OF PATIENTS WITH LUPUS NEPHRITIS - A STUDY BASED ON THE CLASSIFICATION OF THE WORLD-HEALTH-ORGANIZATION [J].

APPEL, GB ;

COHEN, DJ ;

PIRANI, CL ;

MELTZER, JI ;

ESTES, D .

AMERICAN JOURNAL OF MEDICINE, 1987, 83 (05) :877-885

[3] PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA [J].

AUSTIN, HA ;

BOUMPAS, DT ;

VAUGHAN, EM ;

BALOW, JE .

KIDNEY INTERNATIONAL, 1994, 45 (02) :544-550

[4] PROGNOSTIC FACTORS IN LUPUS NEPHRITIS - CONTRIBUTION OF RENAL HISTOLOGIC DATA [J].

AUSTIN, HA ;

MUENZ, LR ;

JOYCE, KM ;

ANTONOVYCH, TA ;

KULLICK, ME ;

KLIPPEL, JH ;

DECKER, JL ;

BALOW, JE .

AMERICAN JOURNAL OF MEDICINE, 1983, 75 (03) :382-391

[5] THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].

AUSTIN, HA ;

KLIPPEL, JH ;

BALOW, JE ;

LERICHE, NGH ;

STEINBERG, AD ;

PLOTZ, PH ;

DECKER, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619

[6] Pathology and pathogenesis of vascular injury in systemic lupus erythematosus - Interactions of inflammatory cells and activated endothelium [J].

Belmont, HM ;

Abramson, SB ;

Lie, JT .

ARTHRITIS AND RHEUMATISM, 1996, 39 (01) :9-22

[7] Effects of immunosuppressive drugs during pregnancy [J].

Bermas, BL ;

Hill, JA .

ARTHRITIS AND RHEUMATISM, 1995, 38 (12) :1722-1732

[8] CEREBROSPINAL-FLUID ANTIBODIES TO NEURONAL CELLS - ASSOCIATION WITH NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

BLUESTEIN, HG ;

WILLIAMS, GW ;

STEINBERG, AD .

AMERICAN JOURNAL OF MEDICINE, 1981, 70 (02) :240-246

[9] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].

BOMBARDIER, C ;

GLADMAN, DD ;

UROWITZ, MB ;

CARON, D ;

CHANG, CH .

ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640

[10] ASSOCIATION BETWEEN LUPUS PSYCHOSIS AND ANTI-RIBOSOMAL P PROTEIN ANTIBODIES [J].

BONFA, E ;

GOLOMBEK, SJ ;

KAUFMAN, LD ;

SKELLY, S ;

WEISSBACH, H ;

BROT, N ;

ELKON, KB .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :265-271

← 1 2 3 4 5 →